---
title: "XRTX.US (XRTX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/XRTX.US/news.md"
symbol: "XRTX.US"
name: "XRTX.US"
parent: "https://longbridge.com/en/quote/XRTX.US.md"
datetime: "2026-03-08T02:20:47.605Z"
locales:
  - [en](https://longbridge.com/en/quote/XRTX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/XRTX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/XRTX.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/XRTX.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/XRTX.US/news.md)


# XRTX.US (XRTX.US) — Related News

### [XORTX Sets March 24 Shareholder Meeting, Seeks Approval for Share Consolidation and Governance Matters](https://longbridge.com/en/news/277935051.md)
*2026-03-05T12:30:06.000Z*
> XORTX Therapeutics Inc. has scheduled its Annual and Special Meeting for March 24, 2026, in Calgary, where shareholders 

### [XORTX Calls March 24, 2026 Shareholder Meeting to Vote on Share Consolidation and Governance Matters](https://longbridge.com/en/news/277648986.md)
*2026-03-03T15:29:28.000Z*
> XORTX Therapeutics Inc. has scheduled its annual and special shareholders’ meeting for March 24, 2026, to discuss financ

### [XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems | XRTX Stock News](https://longbridge.com/en/news/274882587.md)
*2026-02-04T15:00:00.000Z*
> XORTX Therapeutics Inc. has extended its agreement with Vectus Biosystems to finalize the acquisition of the Renal Anti-

### [Corxel raises $287m as obesity continues to spark investor interest](https://longbridge.com/en/news/273526778.md)
*2026-01-23T11:36:50.000Z*
> Corxel Pharmaceuticals has raised $287 million in a Series D1 financing round to support the development of its lead can
